Surgical Science Sweden AB (publ) (STO:SUS)
30.84
+0.64 (2.12%)
Jul 24, 2026, 5:29 PM CET
STO:SUS Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, STO:SUS stock has a consensus rating of "Buy" and an average price target of kr 59.80. The average 1-year stock price forecast is 93.90% higher than the current stock price, while the lowest is kr 40.00 (+29.70%) and the highest is kr 88.00 (+185.34%).
Price Target: kr 59.80 (+93.90%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for STO:SUS stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
987.60M
from 992.34M
Decreased by -0.48%
Revenue Next Year
1.10B
from 987.60M
Increased by 11.79%
EPS This Year
2.13
from 1.71
Increased by 24.53%
EPS Next Year
2.92
from 2.13
Increased by 37.23%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.